Amendment: SEC Form SC 13G/A filed by The Beauty Health Company
$SKIN
Medical/Dental Instruments
Health Care
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/19/2025 | $3.50 | Buy | Roth Capital |
| 11/15/2023 | $11.00 → $1.50 | Buy → Hold | Jefferies |
| 11/14/2023 | $10.00 → $2.50 | Buy → Hold | Canaccord Genuity |
| 11/14/2023 | Neutral → Underweight | JP Morgan | |
| 11/14/2023 | $12.00 → $2.00 | Overweight → Underweight | Piper Sandler |
| 11/14/2023 | $9.00 → $2.50 | Outperform → Market Perform | TD Cowen |
| 11/14/2023 | Buy → Hold | The Benchmark Company | |
| 11/14/2023 | Mkt Perform → Underperform | Raymond James |
LONG BEACH, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced a refresh of its clinically supported Keravive™ scalp treatment as HydraScalp® with Keravive™, marking the next evolution in its scalp health offering. HydraScalp with Keravive is a professional, non-invasive, in-office treatment powered by Hydrafacial's proprietary Vortex-Fusion™ Technology and Keravive biomimetic peptides to deeply cleanse, exfoliate and nourish the scalp. By removing buildup and delivering targeted key ingredients to the scalp, the treatment helps create an optimal scalp environment for
LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN) ("SkinHealth Systems" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 ("Q1 2026"). "First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution. "While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execut
LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the investor relations section of the Company's website at www.skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Informa
8-K/A - SkinHealth Systems Inc. (0001818093) (Filer)
8-K - SkinHealth Systems Inc. (0001818093) (Filer)
10-Q - SkinHealth Systems Inc. (0001818093) (Filer)
4 - Beauty Health Co (0001818093) (Issuer)
3 - SkinHealth Systems Inc. (0001818093) (Issuer)
3 - SkinHealth Systems Inc. (0001818093) (Issuer)
3 - SkinHealth Systems Inc. (0001818093) (Issuer)
Roth Capital initiated coverage of The Beauty Health Company with a rating of Buy and set a new price target of $3.50
Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously
Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously
LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced the appointment of three new independent directors to its Board of Directors (the "Board"): Mr. Kenneth Tripp, Dr. Sachin Shridharani, and Mr. E. Scott Beattie, each effective as of April 17, 2026. "These three appointments reflect exactly the kind of Board we are building at SkinHealth Systems – one that brings extensive operational expertise in medtech, deep clinical authority in aesthetics, and proven leadership in scaling iconic global consumer brands," said Brent Saunders, Chairman of SkinHealth Systems
LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025. Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Soltégo, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson & Johnson, and L'Oré
Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of Pedro Malha as President and Chief Executive Officer, effective October 1, 2025. He succeeds Marla Beck, who is stepping down as President and CEO effective September 30, 2025, and will remain in an advisory role. Brent Saunders, Chairman of the Board, stated, "Pedro is an accomplished leader with broad industry experience at lea
LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN) ("SkinHealth Systems" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 ("Q1 2026"). "First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution. "While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execut
LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the investor relations section of the Company's website at www.skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Informa
LONG BEACH, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2025 ("Q4 2025"). "Our fourth quarter results reflects meaningful structural progress in margins, profitability, and balance sheet strength as our operational improvements are beginning to take hold," said Pedro Malha, President and CEO of BeautyHealth. "BeautyHealth enters 2026 with a strong foundation — a globally recognized brand, one of the largest installed bases in aesthetics, and a strong recurring consumables model. Our focus no
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)
SC 13G/A - Beauty Health Co (0001818093) (Subject)